Here are four key notes:
1. Medicrea acquired the patents from Paul McAfee, MD, of the University of Maryland St. Joseph’s Medical Center in Towson. The patents addressed methodology to measure and plan interbody devices used in spine surgery.
2. The patents protect intellectual property around the technique for physiologically selecting interbody device height based on patient anatomy. The company expects these patents to compliment its UNiD ASI platform.
3. Medicrea takes a systems approach to spine with engineering services and in-house 3-D printing capabilities to create interbody device solutions optimized for the individual patient. The company’s FDA-cleared IB3D and AdapTEK systems give surgeons control over implant design and dimensions.
4. The company will fully integrate its new patents into the proprietary UNiD HUB surgical planning software. “Combining data-driven planning techniques with the ability to deliver personalized implants will significantly reduce the inventory required for each case while ensuring the optimal implant is provided for the patient at each level operated,” said Denys Sourmac, president and CEO of Medicrea.
More articles on orthopedic devices:
7 new spine, orthopedic device launches & releases
Medtronic CEO Omar Ishrak on Q2: Hurricanes, value-based care, China & more: 5 key quotes
J&J reports declining spine sales in Q3—what to expect in Q4
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
